Tina Broby Mikkelsen1, Bente Sørensen2, Karin B Dieperink3,4. 1. Knowledge Centre for Rehabilitation and Palliative Care, Vestergade 17, 5800, Nyborg, Denmark. Tina.broby.mikkelsen@rsyd.dk. 2. Department of Oncology, Lillebaelt Hospital Vejle, Kabbeltoft 25, 7100, Vejle, Denmark. 3. Knowledge Centre for Rehabilitation and Palliative Care, Vestergade 17, 5800, Nyborg, Denmark. 4. Department of Oncology, Odense University Hospital, Sdr. Boulevard 29, Indgang 99, 2. Sal, 5000, Odense C, Denmark.
Abstract
PURPOSE: Women treated for cervical cancer with radiotherapy and chemotherapy have reported serious bowel, vaginal, and sexual late effects. The purpose of this study was to describe late adverse effects, health-related quality of life, and self-efficacy in a representative Danish cervical cancer population in order to describe rehabilitation needs. METHODS: Women, mean age 55 years, treated for cervical cancer from January 2010 to July 2013, who were alive and without known relapse/metastases were included in this cross-sectional study. EORTC QLQ C30 and CX24 and self-efficacy questionnaires were sent to all participants. RESULTS: The participation rate was 85/107 (79%). Participants below 45 years had significantly more menopausal symptoms and lower body image scores compared to elderly women. The frequency of participants with menopausal symptoms decreased with time since diagnosis. Symptom experience was significantly higher in participants with locally advanced disease than in those with local disease. Self-efficacy was significantly lower in participants with locally advanced disease. The incidence of lymphedema was significantly higher among participants who were obese. Multiple analyses showed impaired quality of life, e.g., a lower body image and self-efficacy score, correlated with increasing BMI. Women who had surgery had greater risk of lymphedema, and women who received chemotherapy during treatment had a lower quality of life. All but one received radiotherapy. CONCLUSION: This study found that young, obese survivors with locally advanced cervical cancer and survivors who received chemotherapy may have a serious risk of developing late adverse effects; thus, rehabilitation should target these needs.
PURPOSE:Women treated for cervical cancer with radiotherapy and chemotherapy have reported serious bowel, vaginal, and sexual late effects. The purpose of this study was to describe late adverse effects, health-related quality of life, and self-efficacy in a representative Danish cervical cancer population in order to describe rehabilitation needs. METHODS:Women, mean age 55 years, treated for cervical cancer from January 2010 to July 2013, who were alive and without known relapse/metastases were included in this cross-sectional study. EORTC QLQ C30 and CX24 and self-efficacy questionnaires were sent to all participants. RESULTS: The participation rate was 85/107 (79%). Participants below 45 years had significantly more menopausal symptoms and lower body image scores compared to elderly women. The frequency of participants with menopausal symptoms decreased with time since diagnosis. Symptom experience was significantly higher in participants with locally advanced disease than in those with local disease. Self-efficacy was significantly lower in participants with locally advanced disease. The incidence of lymphedema was significantly higher among participants who were obese. Multiple analyses showed impaired quality of life, e.g., a lower body image and self-efficacy score, correlated with increasing BMI. Women who had surgery had greater risk of lymphedema, and women who received chemotherapy during treatment had a lower quality of life. All but one received radiotherapy. CONCLUSION: This study found that young, obese survivors with locally advanced cervical cancer and survivors who received chemotherapy may have a serious risk of developing late adverse effects; thus, rehabilitation should target these needs.
Entities:
Keywords:
Cervical cancer; Health-related quality of life; Late effects; Rehabilitation needs; Self-efficacy
Authors: Kathryn H Schmitz; Marian L Neuhouser; Tanya Agurs-Collins; Krista A Zanetti; Lisa Cadmus-Bertram; Lorraine T Dean; Bettina F Drake Journal: J Natl Cancer Inst Date: 2013-08-29 Impact factor: 13.506
Authors: Quirine D Pieterse; Gemma G Kenter; Cornelis P Maas; Cor D de Kroon; Carien L Creutzberg; J Baptist M Z Trimbos; Moniek M Ter Kuile Journal: Int J Gynecol Cancer Date: 2013-11 Impact factor: 3.437
Authors: G Bifulco; N De Rosa; M L Tornesello; R Piccoli; A Bertrando; G Lavitola; I Morra; A Di Spiezio Sardo; F M Buonaguro; C Nappi Journal: Gynecol Oncol Date: 2011-11-23 Impact factor: 5.482
Authors: Therese Juul; Morten Aagaard Petersen; Bernhard Holzner; Søren Laurberg; Peter Christensen; Mogens Grønvold Journal: Qual Life Res Date: 2014-03-28 Impact factor: 4.147
Authors: K Kirchheiner; R Nout; J Lindegaard; P Petrič; E V Limbergen; I-M Jürgenliemk-Schulz; C Haie-Meder; R Pötter; W Dörr Journal: Strahlenther Onkol Date: 2012-08-17 Impact factor: 3.621
Authors: Nora T Kizer; Premal H Thaker; Feng Gao; Israel Zighelboim; Matthew A Powell; Janet S Rader; David G Mutch; Perry W Grigsby Journal: Cancer Date: 2010-10-13 Impact factor: 6.860
Authors: N K Aaronson; S Ahmedzai; B Bergman; M Bullinger; A Cull; N J Duez; A Filiberti; H Flechtner; S B Fleishman; J C de Haes Journal: J Natl Cancer Inst Date: 1993-03-03 Impact factor: 13.506
Authors: Christina M Wilson; Deborah B McGuire; Beth L Rodgers; R K Elswick; Sarah M Temkin Journal: Cancer Nurs Date: 2021 Sep-Oct 01 Impact factor: 2.592